• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS1000976 复方蒿甲醚片 artemether;Benflumetolum Tablet Chemical Drugs(6) Generic Drug 2011-05-09 桂林南药股份有限公司 Guilin Pharmaceutical Co Ltd Certificate Issued 2015-10-20 view
CXL20022779 蒿甲醚片 artemether Tablet Chemical Drugs(5) New Drug Application 2002-10-29 昆明制药集团股份有限公司 KPC Pharmaceuticals Inc Pending Approval 2003-05-20 view
CXHB0500383 蒿甲醚片 artemether Tablet Chemical Drugs Supplementary Application 2005-03-24 昆明制药集团股份有限公司 KPC Pharmaceuticals Inc Certificate Issued 2006-01-16 view
CYHB0500469 蒿甲醚片 artemether Tablet Chemical Drugs Supplementary Application 2005-03-17 昆明制药集团股份有限公司 KPC Pharmaceuticals Inc Certificate Issued 2006-01-16 view
CXL20022778 蒿甲醚片 artemether Tablet Chemical Drugs(5) New Drug Application 2002-10-29 昆明制药集团股份有限公司 KPC Pharmaceuticals Inc Certificate Issued 2003-07-07 view
CXL20022780 蒿甲醚片 artemether Tablet Chemical Drugs(5) New Drug Application 2002-10-29 昆明制药集团股份有限公司 KPC Pharmaceuticals Inc Pending Approval 2002-10-30 view
CYHB0502146 蒿甲醚片 artemether Tablet Chemical Drugs Supplementary Application 2005-07-01 昆明制药集团股份有限公司 KPC Pharmaceuticals Inc Certificate Issued 2006-01-16 view
CYHB1306880 复方蒿甲醚片 artemether;Benflumetolum Tablet Chemical Drugs Supplementary Application 2013-10-15 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2014-02-26 view
CYHB1205031 复方蒿甲醚片 artemether;Benflumetolum Tablet Chemical Drugs Supplementary Application 2012-07-25 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2013-06-18 view
CYHB1904010 复方蒿甲醚片 artemether;Benflumetolum Tablet Chemical Drugs Supplementary Application 2019-07-22 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2020-02-26 view
CYHB2200156 复方蒿甲醚片 artemether;Benflumetolum Tablet Chemical Drugs Supplementary Application 2022-01-18 Beijing Novartis Pharma Co Ltd view